Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
US8501786B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2009 |
| Grant date | Aug 6, 2013 |
| Priority date | — |
| Expiry date | Oct 15, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula I, pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.